Welcome back to Stockhouse Member Sign In
Sign in with one of the following accounts.
Send my password
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Use one of the following accounts.
Enrollment wraps up in randomized Phase II study of REOLYSIN®
Everything you could ever want to know about biotech, biomed and bio investments up north.
Before acquiring anything, Merck might just wait to see how Immunovaccine's trials using their own Survivin cancer antigen go. Merck...
List of all shareholders: http://money.cnn.com/quote/shareholders/shareholders.html?symb=ONCY&subView=institutional
EMA has adopted a positive opinion on the reovirus: Human reovirus type 3 Dearing strain for treatment of ovarian cancer, Oncolytics...
I checked the link in stagal’s CPP post. It was a very surprising disclosure of large holdings. I thought that the link would duplicate...
Just a short downturn - profit takers are moving too quickly. This one is going places!